Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer

Background: Local control following trimodality therapy (TMT) for muscle-invasive bladder cancer (MIBC) requires further optimization. Objective: Evaluating the biologic endpoint, feasibility, and toxicity of integrating everolimus to TMT in patients with MIBC. Methods: This was a phase I trial in p...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Bladder Cancer
Päätekijät: Bachir, Bassel G., Souhami, Luis, Mansure, Jose João, Cury, Fabio, Vanhuyse, Marie, Brimo, Fadi, Aprikian, Armen G., Tanguay, Simon, Sturgeon, Jeremy, Kassouf, Wassim
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: IOS Press 2017
Aiheet:
Research Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5409045/
https://ncbi.nlm.nih.gov/pubmed/28516155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-160090
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia